Medibank shares remain in limbo after customer data hack confirmed

Hackers claim to have taken 200GB of customer data from Medibank…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Medibank Private Ltd (ASX: MPL) shares won't be going anywhere today.

This afternoon, Australia's largest private health insurance provider released another update on its cyber incident.

Unfortunately, things have continued to get worse for Medibank and it has requested that it shares remain halted until the matter is resolved.

A man sits in casual clothes in front of a computer amid graphic images of data superimposed on the image, as though he is engaged in IT or hacking activities.

Image source: Getty Images

What's going on?

As readers may be aware, last week Medibank revealed that it had detected unusual activity on its network. At the time it didn't believe that customer data had been taken from its systems.

However, last night the company advised that it had received messages from a group claiming to have removed customer data and wanting to negotiate a ransom for it.

This afternoon, Medibank revealed that this group has claimed to have taken 200GB of customer data from its systems.

As proof, the group has provided a sample of the data to Medibank. That data includes names, addresses, dates of birth, Medicare numbers, policy numbers, phone numbers, and some claims data. The latter includes the location of where a customer received medical services, and codes relating to their diagnosis and procedures.

Other data that the group claims to have taken includes data related to credit card security. Though, this has not been confirmed by its investigations.

However, given that Medibank's team (worryingly) couldn't even tell that 200GB of data had been taken from its systems last week, it may be prudent to assume that what the group is saying is accurate about credit card data.

Given the nature of the information that has been taken, Medibank advised that it is in discussions with government stakeholders about what it can do to assist its customers in safeguarding their identities and health information.

Medibank's CEO, David Koczkar, added:

I unreservedly apologise for this crime which has been perpetrated against our customers, our people, and the broader community. I know that many will be disappointed with Medibank and I acknowledge that disappointment.

This cybercrime is now the subject of an investigation by the Australian Federal Police. We will learn from this incident and will share our learnings with others. Medibank will remain open and transparent and will continue to provide comprehensive updates as often as we can and need to.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A group of people in a corporate setting do a collective high five.
Healthcare Shares

ASX 300 healthcare stock outperforming today on 'strategic' leadership news

The ASX healthcare stock announced the outcome of its CEO recruitment drive this morning.

Read more »

Cropped shot of a young female scientist working on her computer in the laboratory.
Healthcare Shares

Could Telix shares be a millionaire-maker stock?

Telix looks a compelling growth story, with brokers eyeing more than 150% upside.

Read more »

A child covering his eyes hiding from a toy bear.
Healthcare Shares

Down 20% in 2026, is now the time to buy CSL shares?

CSL shares hit a new multi-year low as the 2026 decline deepens.

Read more »

Scientists in white coats look disappointed.
Healthcare Shares

Down 87% since Thursday, why is this ASX 300 healthcare stock sliding again today?

The ASX healthcare share has plunged more than 87% in five trading days.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Which ASX biotech's shares have jumped more than 10% on positive clinical trial news?

A potential cancer treatment is progressing.

Read more »

Man jumps for joy in front of a background of a rising stocks graphic.
Healthcare Shares

3 ASX healthcare stocks tipped to soar over 100% higher this year

These ASX shares are on my radar this week.

Read more »

Scientists working in the laboratory and examining results.
Opinions

3 reasons to buy CSL shares today

The ASX biotech company has great growth potential this year.

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »